The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer
Young Kwang Chae(Johns Hopkins University), Ana M. González-Angulo(The University of Texas MD Anderson Cancer Center)
Cited by 17
Related Papers
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
|Journal for ImmunoTherapy of Cancer|2018|467
Repurposing metformin for cancer treatment: current clinical studies
|Oncotarget|2016|313
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
|Journal of Cancer|2014|59